LBA
Letko, Brosseau & Associates Portfolio holdings
AUM
$5.23B
1-Year Return
15.79%
This Quarter Return
+15.02%
1 Year Return
+15.79%
3 Year Return
+49.62%
5 Year Return
+161.51%
10 Year Return
+219.13%
AUM
$5.55B
AUM Growth
+$508M
(+10%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-2.06%
Top 10 Holdings %
Top 10 Hldgs %
33.64%
Holding
105
New
4
Increased
21
Reduced
62
Closed
8
Top Buys
| 1 |
EFXT
Enerflex
EFXT
|
$44.4M |
| 2 |
FedEx
FDX
|
$26.7M |
| 3 |
GSK
GSK
|
$22.2M |
| 4 |
Rogers Communications
RCI
|
$20M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
$9.32M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$27.5M |
| 2 |
Cenovus Energy
CVE
|
$25M |
| 3 |
Merck
MRK
|
$22.9M |
| 4 |
Canadian Natural Resources
CNQ
|
$20.3M |
| 5 |
Sabesp
SBS
|
$18.6M |
Sector Composition
| 1 | Financials | 29.2% |
| 2 | Communication Services | 16.02% |
| 3 | Energy | 12.23% |
| 4 | Materials | 11.6% |
| 5 | Technology | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Spirit AeroSystems
SPR
$4.84B
| $15.4M | 0.28% |
519,620
-140,925
| -21% | -$4.17M |
|
77
Credicorp
BAP
$20.6B
| $14M | 0.25% |
103,250
+9,000
| +10% | +$1.22M |
|
|
PROF
78
Profound Medical
PROF
$133M
| $12.6M | 0.23% |
1,180,425
-75,250
| -6% | -$805K |
|
79
SPDR S&P Biotech ETF
XBI
$5.28B
| $6.47M | 0.12% |
+78,000
| New | +$6.47M |
|
80
Yatra Online
YTRA
$87.5M
| $5.27M | 0.1% |
2,188,020
| – | – |
|
|
PDS
81
Precision Drilling
PDS
$774M
| $4.81M | 0.09% |
62,812
-5,528
| -8% | -$423K |
|
82
Warner Bros
WBD
$29.1B
| $2.67M | 0.05% |
281,420
-286,817
| -50% | -$2.72M |
|
83
Charles Schwab
SCHW
$177B
| $1.82M | 0.03% |
21,846
| – | – |
|
84
Vanguard Total World Stock ETF
VT
$51.8B
| $1.06M | 0.02% |
12,325
| – | – |
|
85
MetLife
MET
$54.4B
| $937K | 0.02% |
12,949
-150
| -1% | -$10.9K |
|
86
ING
ING
$71.7B
| $853K | 0.02% |
70,060
-21,190
| -23% | -$258K |
|
87
Enbridge
ENB
$105B
| $416K | 0.01% |
10,650
| – | – |
|
88
Duke Energy
DUK
$94B
| $319K | 0.01% |
3,100
| – | – |
|
89
Fortis
FTS
$25B
| $295K | 0.01% |
7,375
| – | – |
|
90
Outset Medical
OM
$237M
| $293K | 0.01% |
757
-743
| -50% | -$288K |
|
91
Kimberly-Clark
KMB
$42.9B
| $275K | 0.01% |
2,025
| – | – |
|
92
Alphabet (Google) Class A
GOOGL
$2.81T
| $244K | ﹤0.01% |
2,760
| – | – |
|
93
Replimune Group
REPL
$454M
| $205K | ﹤0.01% |
7,525
-15,275
| -67% | -$415K |
|
|
94
Cenovus Energy Inc. Warrants (each warrant entitles the holder to purchase one common share at an exercise price of C$6.54 per share)
CVE.WS
$40.3M
| $194K | ﹤0.01% |
15,254
| – | – |
|
|
BLU
95
DELISTED
BELLUS Health Inc.
BLU
| $132K | ﹤0.01% |
+16,000
| New | +$132K |
|
|
MDNA
96
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $77.9K | ﹤0.01% |
170,000
+70,000
| +70% | +$32.1K |
|
97
Atara Biotherapeutics
ATRA
$89.9M
| $57.4K | ﹤0.01% |
700
+72
| +11% | +$5.9K |
|
98
Fluor
FLR
$6.7B
| – | – |
-270,520
| Closed | -$6.73M |
|
99
Heron Therapeutics
HRTX
$202M
| – | – |
-57,200
| Closed | -$241K |
|
100
Nucor
NUE
$33.3B
| – | – |
-2,150
| Closed | -$230K |
|